Table 2.

Characteristics of the Study Population of Forty-six Women with Vaginal Symptoms

All Women (n = 46)Intervention Group (n = 24)Control Group (n = 22)
Age (years) (mean [SD])32 (7.6)31.6 (7.7)32.5 (7.7)
    Range21–48(21–47)(22–48)
Nulliparous (n [%])7 (15)4 (17)3 (14)
Gravity (mean [SD])3.3 (2.6)3.3 (2.0)3.4 (3.2)
    Range1–151–71–15
Sexually active (n [%])39 (85)19 (80)20 (91)
History of STD18 (39)8 (33)10 (45)
Current contraceptive use* (n [%])5 (11)1 (4)4 (18)
Current antibiotic usage (n [%])3 (7)0 (0)3 (14)
Study site (n)
    FHC402020
    Phillips642
Chief complaint
    Itching (n [%])16 (35)9 (38)7 (32)
    Odor (n [%])16 (35)8 (33)8 (37)
    Discharge(n [%])9 (20)3 (13)6 (27)
    Irritation (n [%])3 (7)2 (8)1 (5)
    Other (n [%])2 (4)2 (8)0 (0)
Self therapy (n [%])14 (30)7 (29)7 (32)
    Clotrimazole10
    Douche20
    Tioconazole34
    Vagisil33
    Zinc oxide01
    Wipees10
    Homeopathy01
  • * The woman in the intervention group used oral contraceptive pills. Two women in the control group used oral contraceptive pills and 2 used Depo-Provera.

  • Some women took more than one therapy. Specific types of self-therapy shown as n.

  • STD, sexually transmitted disease; FHC, family health center.